# Charles E. Myers

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/charles-e-myers/

## Facts

| Field | Value |
| --- | --- |
| Citations | 20,493 |
| Field | Pharmaceutical Practices and Patient Outcomes |
| h-index | 77 |
| i10-index | 165 |
| OpenAlex ID | https://openalex.org/A5065139905 |
| ORCID iD | https://orcid.org/0000-0002-5086-7388 |
| Works | 315 |

## Researcher papers

- [Eligibility and Response Guidelines for Phase II Clinical Trials in Androgen-Independent Prostate Cancer: Recommendations From the Prostate-Specific Antigen Working Group](https://scholariq.org/papers/eligibility-and-response-guidelines-for-phase-ii-clinical-trials-in-androgen/)

## Researcher topics

- [Pharmaceutical Practices and Patient Outcomes](https://scholariq.org/topics/pharmaceutical-practices-and-patient-outcomes/)
- [Chemotherapy-induced cardiotoxicity and mitigation](https://scholariq.org/topics/chemotherapy-induced-cardiotoxicity-and-mitigation/)
- [Prostate Cancer Treatment and Research](https://scholariq.org/topics/prostate-cancer-treatment-and-research/)
- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)
- [Ovarian cancer diagnosis and treatment](https://scholariq.org/topics/ovarian-cancer-diagnosis-and-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.